Swedish infection diagnostics company Q-linea AB has secured a group purchasing contract with Premier, Inc., effective September 1, 2026. The agreement provides over 4,000 U.S. member hospitals with pre-negotiated pricing for Q-linea's rapid antimicrobial susceptibility testing system, ASTar.
Q-linea AB has been awarded a national group purchasing contract position with Premier, Inc., a prominent U.S. healthcare improvement company. Effective September 1, 2026, the agreement allows more than 4,000 Premier member hospitals across the United States to access special pricing and terms for Q-linea’s ASTar instrument and ASTar BC G- kit, with no formal end date specified in the initial arrangement.
Founded in 2008 and based in Uppsala, Sweden, Q-linea AB is an innovative diagnostics firm specializing in rapid antimicrobial susceptibility testing for sepsis and severe infections. Premier, Inc., headquartered in Charlotte, North Carolina, operates a leading group purchasing organization and technology platform that unites health systems, providers, and suppliers to streamline supply chain management and improve clinical workflows.
By securing a contract position with Premier, Q-linea dramatically simplifies the procurement process for thousands of healthcare providers, eliminating the need for complex, institution-by-institution contract negotiations. The ASTar system delivers fully automated, phenotypic results directly from positive blood cultures in roughly six hours, enabling clinicians to prescribe targeted antibiotic therapy significantly faster than traditional diagnostic protocols allow.
This arrangement addresses a critical bottleneck in acute infection management, where delays in identifying correct antimicrobial treatments increase patient mortality and elevate overall hospital expenditure. For healthcare providers, rapid diagnostic adoption plays a pivotal role in strengthening antibiotic stewardship programs, combatting antimicrobial resistance, and curtailing prolonged inpatient stays.
From a commercial standpoint, entering Premier’s extensive supply chain network represents a milestone in Q-linea’s expansion into the American healthcare market. By reducing sales friction and accelerating institutional adoption, the partnership enhances Q-linea’s competitive positioning in infection diagnostics while offering Premier members pre-negotiated cost efficiencies for advanced diagnostic technology.
About GlobeNewsInfo
GlobeNewsInfo.com is a business news platform providing latest updates on global business developments, projects, and contract opportunities across diverse sectors and regions. The platform is designed to serve as a trusted source of information for companies, investors, and professionals worldwide.